Our Team

Shanté is a Research Scientist who joined SXT in 2017 and serves as a Drug Inhibition and Drug Metabolism Study Director and Drug Transport Lead Scientist for multiple nonclinical, drug interaction-related contract studies. So let’s get to know more about her!

Agility and focused growth allow drug developers to outsource expertise and benefit the industry at-large by fostering innovation. Panelists at the 2021 Annual DMDG Meeting…

As part of our Meet the Scientist series, we introduce you to one of our most notable product experts, Stephanie Helmstetter.

As part of our Meet the Scientist series, we introduce you to one of our most notable Enzyme Inhibition experts, Lois Haupt.

We pride ourselves on providing cutting edge science for the betterment of humankind, but we’re not the only one. SEKISUI...

As we begin this summer, many of us are grieving opportunities lost for parties and pool days with friends and...

We have welcomed a new consultant to the team! Dr. Pallavi Limaye now serves as a Director in the Scientific...

As a global Life Sciences and Healthcare company, SEKISUI XenoTech recognizes the seriousness of the Coronavirus Pandemic. We are constantly...

Moving a new drug from lab to market is difficult, time-consuming and expensive for any size pharmaceutical or biotechnology company....

At SEKISUI, we pride ourselves on our 3S Principles ­– the values and standards that guide our businesses and shape...